Abstract
Popular cancer therapies face extreme disadvantages, including multimedicament tolerance and non-target impact. These issues will lead to poorer patient conformity and poor levels of survival. Successful medical therapies for cancer patients are desperately required. Nano-particulate structures with a pluronic base represent revolutionary platforms for anti-cancer agent provision. These structures provide great potential for the advancement of cancer therapy due to their pharmacological properties and sufficient physicochemical characteristics. This review aims to offer a more detailed description of the pluronic drug delivery mechani sms that are currently available and explains pluronic as a medicinal polymer. Hydrophobic payload formulations and updated, targeted distribution mechanisms are explained based on pluronic formulations. This analysis offers a rundown of the current situation art related to the theranostic application of polymer micelles targeting the microenvironment of cancer cells. Some guidelines for the future scope and possible opportunities are also been addressed. Search criteria: Primary sources such as Medline a principal component of PubMed, an online, searchable, and biomedical and life science research literature database has been used. It brings readers to almost any area of interest with research and journal articles. One of the internet resources of importance to get scientific publications is specialized scientific search engines known as Google Scholar a database of research material that can be searched for. I have used the online electronic access portal of Elsevier, such as Science Direct to its publications. Scopus is the biggest abstract and peer-reviewed literature database for scientific journals, books, and conference work. Keywords like Cancer, Pluronic, Nanoparticles, Chemotherapy, Cancer, Theranostic, Targeted, Micelles, and Core-shell are crucial as they notify search engines of the content of the site. Range of years: 1992-2020.
Highlights
Every year, cancer causes millions of deaths globally and while there have been significant strides in treatment, several problems need to be solved to strengthen cancer therapy
We will discuss in detail the latest developments in basic and applied nanotechnology, theranostic approach that have led to the development of developed nanoscale materials as ground breaking prototypes for biomedical applications and tailored targeted treatment for cancer [3]
The effectiveness of the strategy is dependent on the combination of recent trends in nanomedicine care with targeted cytotoxic drug nanocarrier allowing for sustained release, site-specific delivery, and dissemination, reduction, or even elimination
Summary
Cancer causes millions of deaths globally and while there have been significant strides in treatment, several problems need to be solved to strengthen cancer therapy. The sustained circulation in the bloodstream of the PTX-charged Pluronic NPs, resulting in improved tumor tissue targeting ability, was predicted to increase over that of the surfactant-based PTX, due to PEO blocks in pluronic F-68. The issues with conventional chemotherapy, such as a lack of precise targeting of the tumor and drug resistance, have been resolved with NP, whereby traditional chemotherapy has been improved [159,160,161] Of these pluronic NPs, promising carriers have been identified in targeted cancer therapy. Theranostic functional pluronic polymer micelles have shown tremendous promise in contrast to traditional therapies to enhance and track medication delivery after administration, which can improve drug effectiveness and mitigate off-target toxicity. Pluronic intelligent nano micelles will open the door for understanding the pathways of cancer that are at the core of the diseases, including the EpithelialMesenchymal Transition (EMT)-related methods
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
